On the other hand, gliomas harboring IDH mutations can be subdivided into two subclasses: those presenting chromosome 1p/19q co-deletion, referred historically as oligodendrogliomas; and those without 1p/19q co-deletion, representing astrocytomas [42]. This evidence concerns the gene IDH2 and central nervous system cancer.